RESEARCH AND DEVELOPMENT COLLABORATION, OPTION AND LICENSE AGREEMENT BETWEEN SMITHKLINE BEECHAM CORPORATION D/B/A GLAXOSMITHKLINE and ANACOR PHARMACEUTICALS, INC.Research and Development Collaboration, Option and License Agreement • November 3rd, 2010 • Anacor Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 3rd, 2010 Company Industry JurisdictionThis RESEARCH AND DEVELOPMENT COLLABORATION, OPTION AND LICENSE AGREEMENT (the "Agreement") is entered into and made effective as of the 5th day of October, 2007 (the "Effective Date") by and between Anacor Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 1060 East Meadow Circle, Palo Alto, CA 94303 ("Anacor"), and SmithKline Beecham Corporation d/b/a GlaxoSmithKline, a Pennsylvania corporation having offices at One Franklin Plaza, Philadelphia, PA 19101 ("GSK"). Anacor and GSK are each referred to herein by name or as a "Party" or, collectively, as "Parties."